Brought to you by 
QLT acquires ophthalmic device company
17 Jan 2012
Executive Summary
Hoping to increase its eye disease business, QLT has acquired the assets of ForSight Newco II, an entity created by ophthalmic products incubator ForSight Labs that is developing an ocular punctal plug drug delivery device.
Deal Industry
- Biotechnology
- Medical Devices
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Controlled Release
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
QLT acquires ophthalmic device company
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice